ACCOUNTS - Final Accounts


Caseware UK (AP4) 2019.0.227 2019.0.227 The principal activity of the Company is that of development of biocatalysis process technologies.The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.392019-05-01false37truetrue SC237393 2019-05-01 2020-04-30 SC237393 2018-05-01 2019-04-30 SC237393 2020-04-30 SC237393 2019-04-30 SC237393 c:Director1 2019-05-01 2020-04-30 SC237393 c:Director2 2019-05-01 2020-04-30 SC237393 d:Buildings d:ShortLeaseholdAssets 2019-05-01 2020-04-30 SC237393 d:Buildings d:ShortLeaseholdAssets 2020-04-30 SC237393 d:Buildings d:ShortLeaseholdAssets 2019-04-30 SC237393 d:PlantMachinery 2019-05-01 2020-04-30 SC237393 d:PlantMachinery 2020-04-30 SC237393 d:PlantMachinery 2019-04-30 SC237393 d:PlantMachinery d:OwnedOrFreeholdAssets 2019-05-01 2020-04-30 SC237393 d:MotorVehicles 2019-05-01 2020-04-30 SC237393 d:MotorVehicles 2020-04-30 SC237393 d:MotorVehicles 2019-04-30 SC237393 d:MotorVehicles d:OwnedOrFreeholdAssets 2019-05-01 2020-04-30 SC237393 d:FurnitureFittings 2019-05-01 2020-04-30 SC237393 d:FurnitureFittings 2020-04-30 SC237393 d:FurnitureFittings 2019-04-30 SC237393 d:FurnitureFittings d:OwnedOrFreeholdAssets 2019-05-01 2020-04-30 SC237393 d:OwnedOrFreeholdAssets 2019-05-01 2020-04-30 SC237393 d:PatentsTrademarksLicencesConcessionsSimilar 2019-05-01 2020-04-30 SC237393 d:PatentsTrademarksLicencesConcessionsSimilar 2020-04-30 SC237393 d:PatentsTrademarksLicencesConcessionsSimilar 2019-04-30 SC237393 d:CurrentFinancialInstruments 2020-04-30 SC237393 d:CurrentFinancialInstruments 2019-04-30 SC237393 d:Non-currentFinancialInstruments 2020-04-30 SC237393 d:Non-currentFinancialInstruments 2019-04-30 SC237393 d:CurrentFinancialInstruments d:WithinOneYear 2020-04-30 SC237393 d:CurrentFinancialInstruments d:WithinOneYear 2019-04-30 SC237393 d:Non-currentFinancialInstruments d:AfterOneYear 2020-04-30 SC237393 d:Non-currentFinancialInstruments d:AfterOneYear 2019-04-30 SC237393 d:ShareCapital 2020-04-30 SC237393 d:ShareCapital 2019-04-30 SC237393 d:SharePremium 2020-04-30 SC237393 d:SharePremium 2019-04-30 SC237393 d:RetainedEarningsAccumulatedLosses 2020-04-30 SC237393 d:RetainedEarningsAccumulatedLosses 2019-04-30 SC237393 c:FRS102 2019-05-01 2020-04-30 SC237393 c:AuditExempt-NoAccountantsReport 2019-05-01 2020-04-30 SC237393 c:FullAccounts 2019-05-01 2020-04-30 SC237393 c:PrivateLimitedCompanyLtd 2019-05-01 2020-04-30 SC237393 d:WithinOneYear 2020-04-30 SC237393 d:WithinOneYear 2019-04-30 SC237393 d:BetweenOneFiveYears 2020-04-30 SC237393 d:BetweenOneFiveYears 2019-04-30 SC237393 d:PatentsTrademarksLicencesConcessionsSimilar d:ExternallyAcquiredIntangibleAssets 2019-05-01 2020-04-30 SC237393 2 2019-05-01 2020-04-30 SC237393 6 2019-05-01 2020-04-30 SC237393 d:AcceleratedTaxDepreciationDeferredTax 2020-04-30 SC237393 d:AcceleratedTaxDepreciationDeferredTax 2019-04-30 SC237393 d:TaxLossesCarry-forwardsDeferredTax 2020-04-30 SC237393 d:TaxLossesCarry-forwardsDeferredTax 2019-04-30 SC237393 d:RetirementBenefitObligationsDeferredTax 2020-04-30 SC237393 d:RetirementBenefitObligationsDeferredTax 2019-04-30 SC237393 d:OtherDeferredTax 2020-04-30 SC237393 d:OtherDeferredTax 2019-04-30 SC237393 d:PatentsTrademarksLicencesConcessionsSimilar d:OwnedIntangibleAssets 2019-05-01 2020-04-30 iso4217:GBP xbrli:pure

Registered number: SC237393










Ingenza Limited








Unaudited

Financial statements

Information for filing with the registrar

For the Year Ended 30 April 2020

 
Ingenza Limited
Registered number: SC237393

Balance Sheet
As at 30 April 2020

2020
2019
Note
£
£

Fixed assets
  

Intangible assets
 4 
43,723
30,297

Tangible assets
 5 
664,396
530,354

Investments
 6 
428,537
20,280

  
1,136,656
580,931

Current assets
  

Debtors: amounts falling due within one year
 7 
1,490,611
1,105,407

Cash at bank and in hand
 8 
1,309,440
1,668,911

  
2,800,051
2,774,318

Creditors: amounts falling due within one year
 9 
(777,407)
(832,472)

Net current assets
  
 
 
2,022,644
 
 
1,941,846

Total assets less current liabilities
  
3,159,300
2,522,777

Creditors: amounts falling due after more than one year
 10 
(212,500)
(297,500)

Provisions for liabilities
  

Deferred tax
 11 
(19,348)
-

  
 
 
(19,348)
 
 
-

Net assets
  
2,927,452
2,225,277


Capital and reserves
  

Called up share capital 
  
106
106

Share premium account
  
64,986
64,986

Profit and loss account
  
2,862,360
2,160,185

  
2,927,452
2,225,277


Page 1

 
Ingenza Limited
Registered number: SC237393

Balance Sheet (continued)
As at 30 April 2020

The Directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The Directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




................................................
Ian Fotheringham
................................................
Jaymin Amin
Director
Director


Date: 26 January 2021
Date:26 January 2021

The notes on pages 3 to 10 form part of these financial statements.

Page 2

 
Ingenza Limited
 

 
Notes to the Financial Statements
For the Year Ended 30 April 2020

1.


General information

Ingenza Limited is a private limited liability company incorporated in Scotland, registration number SC237393. The address of the registered office and principal place of business is Roslin Innovation Centre, Charnock Bradley Building, Easter Bush Campus, Bush Farm Road, Roslin, Scotland, EH25 9RG.
The financial statements are presented in sterling and rounded to the nearest £1.
The principal activity of the company is that of the development of biocatalysis process technologies.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principal accounting policies have been applied:

 
2.2

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss except when deferred in other comprehensive income as qualifying cash flow hedges.

Foreign exchange gains and losses that relate to borrowings and cash and cash equivalents are presented in the Statement of Comprehensive Income within 'finance income or costs'. All other foreign exchange gains and losses are presented in profit or loss within 'other operating income'.

Page 3

 
Ingenza Limited
 

 
Notes to the Financial Statements
For the Year Ended 30 April 2020

2.Accounting policies (continued)

 
2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.4

Operating leases: the Company as lessee

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the lease term.

 
2.5

Research and development

In the research phase of an internal project it is not possible to demonstrate that the project will generate future economic benefits and hence all expenditure on research shall be recognised as an expense when it is incurred. Intangible assets are recognised from the development phase of a project if and only if certain specific criteria are met in order to demonstrate the asset will generate probable future economic benefits and that its cost can be reliably measured. The capitalised development costs are subsequently amortised on a straight line basis over their useful economic lives, which range from 3 to 6 years.
If it is not possible to distinguish between the research phase and the development phase of an internal project, the expenditure is treated as if it were all incurred in the research phase only.

 
2.6

Government grants

Grants are accounted under the accruals model as permitted by FRS 102. Grants relating to expenditure on tangible fixed assets are credited to profit or loss at the same rate as the depreciation on the assets to which the grant relates. The deferred element of grants is included in creditors as deferred income.
Grants of a revenue nature are recognised in the Statement of Comprehensive Income in the same period as the related expenditure.

 
2.7

Interest income

Interest income is recognised in profit or loss using the effective interest method.

Page 4

 
Ingenza Limited
 

 
Notes to the Financial Statements
For the Year Ended 30 April 2020

2.Accounting policies (continued)

 
2.8

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance Sheet. The assets of the plan are held separately from the Company in independently administered funds.

 
2.9

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the Balance Sheet date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

 
2.10

Intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

 The estimated useful lives range as follows:

Patents
-
4
years

 
2.11

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Page 5

 
Ingenza Limited
 

 
Notes to the Financial Statements
For the Year Ended 30 April 2020

2.Accounting policies (continued)


2.11
Tangible fixed assets (continued)

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Leasehold Property Improvements
-
Over term of the lease
Plant & machinery
-
25% Straight line
Leased Bikes
-
33% Straight line
Fixtures, fittings and computer equipment
-
33% Straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.12

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.

 
2.13

Debtors

Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.14

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.15

Creditors

Short term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Page 6

 
Ingenza Limited
 

 
Notes to the Financial Statements
For the Year Ended 30 April 2020

2.Accounting policies (continued)

 
2.16

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.

Debt instruments (other than those wholly repayable or receivable within one year), including loans and other accounts receivable and payable, are initially measured at present value of the future cash flows and subsequently at amortised cost using the effective interest method. Debt instruments that are payable or receivable within one year, typically trade debtors and creditors, are measured, initially and subsequently, at the undiscounted amount of the cash or other consideration expected to be paid or received. However, if the arrangements of a short-term instrument constitute a financing transaction, like the payment of a trade debt deferred beyond normal business terms or in case of an out-right short-term loan that is not at market rate, the financial asset or liability is measured, initially at the present value of future cash flows discounted at a market rate of interest for a similar debt instrument and subsequently at amortised cost, unless it qualifies as a loan from a director in the case of a small company, or a public benefit entity concessionary loan.

Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Statement of Comprehensive Income.


3.


Employees

The average monthly number of employees, including directors, during the year was 39 (2019 - 37).


4.


Intangible assets




Patents

£



Cost


At 1 May 2019
71,137


Additions
27,537



At 30 April 2020

98,674



Amortisation


At 1 May 2019
40,840


Charge for the year on owned assets
14,111



At 30 April 2020

54,951



Net book value



At 30 April 2020
43,723



At 30 April 2019
30,297



Page 7

 
Ingenza Limited
 

 
Notes to the Financial Statements
For the Year Ended 30 April 2020

5.


Tangible fixed assets





Leasehold Property Improvements
Plant & machinery
Leased Bicycles
Fixtures, fittings and equipment
Total

£
£
£
£
£



Cost


At 1 May 2019
425,000
737,373
958
32,030
1,195,361


Additions
-
351,374
-
9,458
360,832


Disposals
-
(144)
-
(2,568)
(2,712)



At 30 April 2020

425,000
1,088,603
958
38,920
1,553,481



Depreciation


At 1 May 2019
56,667
583,151
958
24,231
665,007


Charge for the year on owned assets
85,000
138,287
-
3,494
226,781


Disposals
-
(135)
-
(2,568)
(2,703)



At 30 April 2020

141,667
721,303
958
25,157
889,085



Net book value



At 30 April 2020
283,333
367,300
-
13,763
664,396



At 30 April 2019
368,333
154,222
-
7,799
530,354


6.


Fixed asset investments





Unlisted investments

£



Cost or valuation


At 1 May 2019
20,280


Additions
408,257



At 30 April 2020
428,537




Page 8

 
Ingenza Limited
 

 
Notes to the Financial Statements
For the Year Ended 30 April 2020

7.


Debtors

2020
2019
£
£


Trade debtors
760,080
351,105

Amounts owed by joint ventures and associated undertakings
350,472
350,472

Other debtors
226,622
275,948

Prepayments and accrued income
153,437
90,641

Deferred taxation
-
37,241

1,490,611
1,105,407



8.


Cash and cash equivalents

2020
2019
£
£

Cash at bank and in hand
1,309,440
1,668,911

1,309,440
1,668,911



9.


Creditors: Amounts falling due within one year

2020
2019
£
£

Trade creditors
300,060
281,194

Other taxation and social security
164,003
145,775

Other creditors
194,936
231,522

Accruals and deferred income
118,408
173,981

777,407
832,472



10.


Creditors: Amounts falling due after more than one year

2020
2019
£
£

Other creditors
212,500
297,500

212,500
297,500


Page 9

 
Ingenza Limited
 

 
Notes to the Financial Statements
For the Year Ended 30 April 2020

11.


Deferred taxation




2020


£






At beginning of year
37,241


Charged to profit or loss
(56,589)



At end of year
(19,348)

The deferred taxation balance is made up as follows:

2020
2019
£
£


Accelerated capital allowances
(61,630)
(80,701)

Tax losses carried forward
-
60,113

Short term timing differences
30,211
-

R&D Tax Credit
12,071
57,829

(19,348)
37,241


12.


Pension commitments

The Company operates a defined contributions pension scheme. The assets of the scheme are held separately from those of the Company in an independently administered fund. The pension cost charge represents contributions payable by the Company to the fund and amounted to £121,842 (2019 - £91,233). Contributions totalling £24,108 (2019 - £21,826) were payable to the fund at the balance sheet date.


13.


Commitments under operating leases

At 30 April 2020 the Company had future minimum lease payments due under non-cancellable operating leases for each of the following periods:

2020
2019
£
£


Not later than 1 year
307,933
275,274

Later than 1 year and not later than 5 years
739,040
1,046,973

1,046,973
1,322,247


14.


Related party transactions

In prior years Ingenza paid invoices on behalf of R C Bio Inc, the parent company. At the year end R C Bio Inc owed Ingenza £40,001 (2019 - £40,001) which is included within other debtors.

Page 10